Read the paper on "Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study" here: ow.ly/PIgk30qC5dE #IBD #COVID19

Important data on the outcome of #covid19 in patients with #ibd in Italy Silvio Danese alessandro armuzzi Massimo Fantini MD, PhD Gut Journal gut.bmj.com/content/early/…

My article is featured on the ResearchGate #COVID19 community page. Read it here: researchgate.net/publication/34…

The first case of a patient with severe #ulcerativecolitis and #Covid-19 pneumonia who was successfully treated for both conditions with #Infliximab

gut.bmj.com/cgi/content/fu…

youtu.be/tT7T1j0oxxI Nella video-pillola di oggi, la Dott.ssa Pugliese ci anticipa alcune delle tematiche che verranno affrontate in occasione del XI Congresso Nazionale IGIBD, che si terrà in modalità virtuale dal 29 novembre al 5 dicembre 2020.

The new IG-IBD study “Therapies for IBD do not pose additional risks for adverse outcomes of SARS-CoV-2 infection” is now published. Thanks to the “COVID-19 IG-IBD study group”!!!

Our pelvic ultrasound workshop is underway! Lead by Dan Carter #GiovanniMcConi with fantastic line up of faculty!

Are we sure that #Crohn's patients with 1 risk factor for #POR need immunoprophylaxis after surgery? An IGIBD effort has tried to answer this question. Link to the paper in the first comment👇

When to de-escalate therapy in IBD patients, hot topic discussion at #4Nations, Henit Yanai, IG-IBD, GETECCU, GEDII, GETAID